Comparative efficacy and safety of pharmacological treatments for lower-risk myelodysplastic syndromes: a Systematic Review and network meta-analysis - Scorecard - MDSpire

Comparative efficacy and safety of pharmacological treatments for lower-risk myelodysplastic syndromes: a Systematic Review and network meta-analysis

  • By

  • Haixia Zhang

  • Jiaqiang Hu

  • Yaxi Jiang

  • Lihua Deng

  • Song Liu

  • June 16, 2026

  • 0 min

Share

Clinical Scorecard: Efficacy and Safety Comparison of Drug Therapies for Lower-Risk Myelodysplastic Syndromes: A Systematic Review and Network Meta-Analysis

At a Glance

CategoryDetail
Condition
Key MechanismsPharmacological treatments targeting erythropoiesis, immunomodulation, hypomethylation, and thrombopoiesis.
Target Population
Care Setting

Key Highlights

  • Luspatercept and ESA-based regimens associated with higher HI–E rates.
  • Lenalidomide-containing regimens showed favorable RBC–TI outcomes.
  • Eltrombopag and romiplostim demonstrated potential benefits for HI–P.
  • Safety profiles varied; CC-486 and imetelstat linked to higher neutropenia and gastrointestinal toxicity.

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider pharmacological strategies including ESAs, luspatercept, lenalidomide, and thrombopoietin receptor agonists.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Adults diagnosed with lower-risk myelodysplastic syndromes.

        Therapies targeting distinct biological pathways show variable efficacy across haematological endpoints.

        Clinical Best Practices

          Related Resources & Content

          Original Source(s)

          Comparative efficacy and safety of pharmacological treatments for lower-risk myelodysplastic syndromes: a Systematic Review and network meta-analysis

          • by Haixia Zhang, Jiaqiang Hu, Yaxi Jiang, Lihua Deng, Song Liu

          • June 16, 2026

          Related Content

          Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseases

          Early detection and correction of preoperative anemia in patients undergoing colorectal surgery—a prospective study

          The 51st Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Award Winners (O001-O007)

          • November 5, 2025